• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT MEDICAL EPIC¿ VALVE (MITRAL); HEART-VALVE, NON-ALLOGRAFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT MEDICAL EPIC¿ VALVE (MITRAL); HEART-VALVE, NON-ALLOGRAFT TISSUE Back to Search Results
Model Number E100-29M
Device Problems Calcified (1077); Off-Label Use (1494); Central Regurgitation (4068)
Patient Problems Dyspnea (1816); Tricuspid Valve Insufficiency/ Regurgitation (4453)
Event Date 09/08/2023
Event Type  Injury  
Manufacturer Narrative
Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.
 
Event Description
It was reported that 3 years ago on an unknown date, a 29mm stented porcine,mit,epic was implanted in a patient.The patient reported to have dyspean six month prior to the explant procedure.The patient had vena cava filter due to a venous thrombosis and the device migrated to the heart.When the physician tried to recover it, it got stuck in the native tricuspid valve and ruptured causing sudden severe insufficiency and shock in the patient.An emergency surgery was done on 08 september 2023.The valve was explanted due to calcium noted on the valve, and severe valve regurgitation.A 25mm sjm masters series mechanical heart valve device was implanted as a replacement.The reason why a biological valve was implanted at the time was because the patient did not want to be anticoagulated due to sports issues.The patient remain stable.
 
Manufacturer Narrative
Explant of the device after 3 years due to insufficiency, regurgitation, and fixed leaflets was reported.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed and the product met all specifications.A more comprehensive assessment, including histopathological examination of the valve tissue could not be performed as the device was not returned for analysis.Information from the field indicated that the valve was implanted in the tricuspid position.It was also reported that the valve was calcified, which could have contributed to the reported event.There is no indication of a product quality issue with regards to manufacture, design, or labeling.
 
Manufacturer Narrative
A valve initially implanted to address thrombosis was explanted due to dyspnea, calcification and severe regurgitation was reported.A more comprehensive assessment, including histopathological examination of the valve tissue could not be performed as the device was not returned for analysis.The provided images illustrate pannus present on the valve outflow surface, potentially causing difficulty of leaflet opening, along with torn leaflets.The cause of torn leaflets remains uncertain, whether they occurred during process of implant or explant of the valve.Calcification and regurgitation were noted, which could have contribute to leaflet tears formation.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed and the product met all specifications.The cause of reported incident could not be conclusively determined, but classification of the valve may have contributed to the reported event.There is no indication of a product quality issue with regards to manufacture, design, or labeling.
 
Event Description
It was reported that in approximately 2020, a 29mm epic mitral valve chosen for implant.The patient had an unrelated procedure for a vena cava filter due to a venous thrombosis, and the device migrated to the heart.When the physician tried to recover the filter, it got stuck in the native tricuspid valve and ruptured, causing sudden severe insufficiency and shock in the patient.The 29mm epic mitral valve was implanted in an emergency surgery in approximately 2020.It was later reported that the patient began having dyspnea in approximately (b)(6) 2023.On (b)(6) 2023, the valve was explanted due to calcification and severe valve regurgitation.A 25mm sjm masters series mechanical heart valve was implanted as a replacement device.The patient remain stable.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EPIC¿ VALVE (MITRAL)
Type of Device
HEART-VALVE, NON-ALLOGRAFT TISSUE
Manufacturer (Section D)
ABBOTT MEDICAL
5050 nathan lane n
plymouth MN 55442
Manufacturer (Section G)
ST. JUDE MEDICAL LTDA. REG#3001883144
1301rua profvieira demendonça
bairro engenho nogueira 31.31 0-26
BR   31.310-260
Manufacturer Contact
karen krouse
5050 nathan lane n
plymouth, MN 55442
6517565400
MDR Report Key17878735
MDR Text Key325015420
Report Number2135147-2023-04343
Device Sequence Number1
Product Code LWR
Combination Product (y/n)N
Reporter Country CodeMX
PMA/PMN Number
P040021
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 03/05/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/05/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date04/03/2023
Device Model NumberE100-29M
Device Catalogue NumberE100-29M
Device Lot NumberBR00020710
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received02/13/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured04/04/2019
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age26 YR
Patient SexMale
-
-